Health Affairs  |  July 6, 2023

Read the Publication

Multiple lawsuits have now been brought that encompass a range of constitutional challenges to the Medicare Drug Price Negotiation Program enacted under the Inflation Reduction Act (IRA). More are expected to be filed by the pharmaceutical industry and their allies shortly.

Read more here.

Related Initiatives

Health Policy and the Law

Latest publications See All